Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Segesterone (commonly used as its acetate ester, segesterone acetate) is a potent synthetic progestin of the 19-norprogesterone class. It acts as a high-affinity agonist of the progesterone receptor with minimal activity at androgenic, estrogenic, or mineralocorticoid receptors. Segesterone is primarily used in hormonal contraceptives—most notably in combination with ethinyl estradiol as a vaginal ring (e.g., Annovera)—and for the treatment of endometriosis in some countries. Due to rapid hepatic metabolism and lack of oral bioavailability, it is administered via non-oral routes such as implants or vaginal rings. The drug was developed by the Population Council and has been licensed to companies including TherapeuticsMD for commercial distribution[4][5][6].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on segesterone.